Cargando…

Testosterone, HIV, and cardiovascular disease risk

There has been a recent increase in the use of testosterone supplementation among young adults in the United States, despite the controversy of testosterone replacement therapy (TRT) and cardiovascular safety. The lower testosterone levels and earlier age of TRT use in persons living with HIV (PLHIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grant, Jelani K., Loyd, Quentin, Martinez, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189608/ https://www.ncbi.nlm.nih.gov/pubmed/34124602 http://dx.doi.org/10.1097/XCE.0000000000000236

Ejemplares similares

Early Insights into COVID-19 in Persons Living with HIV and Cardiovascular Manifestations
por: Grant, Jelani K., et al.
Publicado: (2020)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

Testosterone and Cardiovascular Disease
por: Tambo, Amos, et al.
Publicado: (2016)

Cardiac Catheterization Procedures in Patients with HIV: A Retrospective Analysis
por: Ebner, Bertrand, et al.
Publicado: (2021)

Cardiovascular disease and prevention among people living with HIV in South Florida
por: Pyarali, Fahim, et al.
Publicado: (2021)

Testosterone Replacement Therapy and Cardiovascular Risk: A Review
por: Corona G, Giovanni, et al.
Publicado: (2015)

Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
por: Albosta, Michael S, et al.
Publicado: (2023)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
por: Kaur, Hargun, et al.
Publicado: (2021)

Testosterone deficiency and cardiovascular mortality
por: Morgentaler, Abraham
Publicado: (2015)

The putative mechanisms underlying testosterone and cardiovascular risk
por: Maganty, Avinash, et al.
Publicado: (2014)

Are men at risk? The role of testosterone in cardiovascular morbidity
por: Sundivakkam, Premanand C., et al.
Publicado: (2012)

Conclusions about testosterone therapy and cardiovascular risk
por: Anawalt, Bradley D, et al.
Publicado: (2018)

Testosterone Replacement and Cardiovascular Safety: No Straight and Narrow!
por: Hans, Sartaj S, et al.
Publicado: (2015)

Is Testosterone Replacement Safe in Men with Cardiovascular Disease?
por: Ahmed, Talha, et al.
Publicado: (2020)

Welcoming low testosterone as a cardiovascular risk factor
por: Maggio, M, et al.
Publicado: (2009)

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
por: Pantalone, Kevin M., et al.
Publicado: (2019)

Trials of testosterone replacement reporting cardiovascular adverse events
por: Gagliano-Jucá, Thiago, et al.
Publicado: (2018)

Testosterone treatment and cardiovascular events in prescription database studies
por: Shores, Molly M
Publicado: (2018)

Corrigendum: Testosterone Replacement Therapy and Cardiovascular Risk: A Review
por: Corona, Giovanni, et al.
Publicado: (2016)

Why is understanding the relationship of testosterone to cardiovascular risk so important?
por: Yeap, Bu B, et al.
Publicado: (2018)

Endogenous testosterone and mortality risk
por: Meyer, Emily J, et al.
Publicado: (2018)

Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation()
por: Schooling, C. Mary, et al.
Publicado: (2018)

Testosterone and the Cardiovascular System: A Comprehensive Review of the Clinical Literature
por: Oskui, Peyman Mesbah, et al.
Publicado: (2013)

Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system
por: Jones, T Hugh, et al.
Publicado: (2018)

Risks of testosterone replacement therapy in men
por: Osterberg, E. Charles, et al.
Publicado: (2014)

Impact of Testosterone on Alzheimer’s Disease
por: Bianchi, Vittorio Emanuele
Publicado: (2022)

The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
por: Chiang, Cheng-Hung, et al.
Publicado: (2022)

Alternatives to testosterone replacement: testosterone restoration
por: McCullough, Andrew
Publicado: (2015)

Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
por: Gencer, Baris, et al.
Publicado: (2021)

Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men
por: Yeap, Bu B
Publicado: (2018)

Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes
por: Wang, Christina, et al.
Publicado: (2011)

Cardiovascular disease and HIV
por: Martínez, Esteban
Publicado: (2010)

Ginger and Testosterone
por: Banihani, Saleem Ali
Publicado: (2018)

The benefits and risks of testosterone replacement therapy: a review
por: Bassil, Nazem, et al.
Publicado: (2009)

Testosterone and Sarcopenia
por: Shin, Myung Jun, et al.
Publicado: (2018)

Relationship between Serum Testosterone and Cardiovascular Disease Risk Determined Using the Framingham Risk Score in Male Patients with Sexual Dysfunction
por: Lee, Wan Chul, et al.
Publicado: (2014)

Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
por: Atan, Ali, et al.
Publicado: (2013)

Emerging Evidences in the Long Standing Controversy Regarding Testosterone Replacement Therapy and Cardiovascular Events
por: Clavell-Hernández, Jonathan, et al.
Publicado: (2018)

Testosterone Deficiency and Risk of Cognitive Disorders in Aging Males
por: Corona, Giovanni, et al.
Publicado: (2021)

Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans With Low Testosterone Levels and Multiple Medical Comorbidities
por: Shores, Molly M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_abm2u98qce5u9hhf0bjjl8eb19